These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 142253)

  • 21. Increase of opioid mu-receptor gene expression in streptozotocin-induced diabetic rats.
    Cheng JT; Liu IM; Chi TC; Tzeng TF
    Horm Metab Res; 2001 Aug; 33(8):467-71. PubMed ID: 11544560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis.
    Kim JH; Lee DE; Choi SH; Cha JH; Bak EJ; Yoo YJ
    J Periodontal Res; 2014 Dec; 49(6):792-800. PubMed ID: 24490978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings.
    Cossel L; Schneider E; Kuttler B; Schmidt S; Wohlrab F; Schade J; Bochmann C
    Exp Clin Endocrinol; 1985 Feb; 85(1):7-26. PubMed ID: 3157595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetes induction by subdiabetogenic doses of streptozotocin in BALB/cBOM mice. Noninvolvement of host B-lymphocyte functions.
    Blue ML; Shin SI
    Diabetes; 1984 Feb; 33(2):105-10. PubMed ID: 6229438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of nicotinamide administration on the bile-acid pattern in rats given streptozotocin].
    Ogura M; Noda Y; Suzukui T
    Biol Chem Hoppe Seyler; 1990 Jul; 371(7):637-40. PubMed ID: 2145864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility.
    Wright JR; Haliburton B; Russell H; Henry M; Fraser R; Cook HW
    Diabetologia; 1991 Oct; 34(10):709-14. PubMed ID: 1835705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes.
    Rakieten N; Gordon BS; Beaty A; Cooney DA; Schein PS; Dixon RL
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):356-61. PubMed ID: 175379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of gamma-hydroxybutyrate and nicotinamide on low-dose streptozotocin-induced diabetes in mice.
    Bouix O; Reynier M; Guintrand-Hugret R; Orsetti A
    Horm Metab Res; 1995 May; 27(5):216-20. PubMed ID: 7642171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ciamexon in the low dose streptozotocin induced diabetes of mice.
    Linn T; Volkmann A; Germann H; Woehrle M; Bretzel RG; Bicker U; Federlin K
    Diabetes Res; 1987 Nov; 6(3):113-7. PubMed ID: 3325216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.
    Fukudome D; Matsuda M; Kawasaki T; Ago Y; Matsuda T
    Eur J Pharmacol; 2008 Mar; 583(1):164-9. PubMed ID: 18291360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 promotes hyperglycemia and insulitis in mice normally resistant to streptozotocin-induced diabetes.
    Zunino SJ; Simons LF; Sambrook JF; Gething MJ
    Am J Pathol; 1994 Sep; 145(3):661-70. PubMed ID: 8080048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes mellitus in mice induced by multiple subdiabetogenic doses of streptozotocin: age and sex dependence.
    Kuttler B; Schneider E
    Acta Biol Med Ger; 1982; 41(12):1199-1202. PubMed ID: 6231788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model.
    Szkudelski T
    Exp Biol Med (Maywood); 2012 May; 237(5):481-90. PubMed ID: 22619373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B cells with special regard to the role of nicotinamide-adenine dinucleotide.
    Gunnarsson R; Berne C; Hellerström C
    Biochem J; 1974 Jun; 140(3):487-94. PubMed ID: 4374939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetogenic action of streptozotocin: relationship of dose to metabolic response.
    Junod A; Lambert AE; Stauffacher W; Renold AE
    J Clin Invest; 1969 Nov; 48(11):2129-39. PubMed ID: 4241908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The orphan nuclear receptor small heterodimer partner negatively regulates pancreatic beta cell survival and hyperglycemia in multiple low-dose streptozotocin-induced type 1 diabetic mice.
    Noh JR; Hwang JH; Kim YH; Kim KS; Gang GT; Kim SW; Kim DK; Shong M; Lee IK; Choi HS; Lee CH
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1538-45. PubMed ID: 23680671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphologic-histochemical characterization of inflammatory cells in insulitis induced by multiple subdiabetogenic doses of streptozotocin in C57B1/KsJ mice.
    Schneider E; Wohlrab F; Cossel L
    Biomed Biochim Acta; 1984; 43(5):683-90. PubMed ID: 6236802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice.
    Wright JR; Lefkowith JB; Schreiner G; Lacy PE
    Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6137-41. PubMed ID: 3045812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.